Compound Description

2,6-Piperidinedione, 4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1α(S*),3α,5β]]-;

Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-;

Naramycin A;

4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-2,6-piperidinedione;

(-)-Cycloheximide;

3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide;

Acti-Aid;

Acti-dione;

Acti-dione BR;

Acti-dione PM;

Acti-dione TGF;

Actidion;

CHX;

Cicloheximide;

Cycloheximide;

FT 3422-2;

LDN 97549;

NM-MCD 80;

NSC 185;

Naramycin;

Naramycin Microcapsule D 80;

Naramycin NM-MCU 80;

TZA;

U 4527;

l-Cycloheximide;

β-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide